Can vitamin E prevent development of coronary heart disease?;Kan vitamin E forebygge utvikling av koronar hjertesykdom?

Tidsskrift for den Norske Laegeforening

Volumn 116, Issue 9, 1996, Pages 1109-1113

  Nguyen, Khang Ngoc ^a   Landmark, Knud ^a  

^a UNIVERSITY OF OSLO   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT;

CORONARY ARTERY DISEASE; FEMALE; HUMAN; MALE; REVIEW;

ANTIOXIDANTS; CORONARY DISEASE; FEMALE; HUMANS; MALE; VITAMIN E;

EID: 0030606423     PISSN: 00292001     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (61)

1. Næss K. E-vitamin. Tid for revurdering. Tidsskr Nor Lægeforen 1972; 92: 2286-8.
2. Blomhoff R, Drevon CA. Fettløselige vitaminer i klinisk praksis. Tidsskr Nor Lægeforen 1995; 115: 481-5.
3. Henriksen T, Endresen M. Oksidativt stress og antioksidanter. Tidsskr Nor Lægeforen 1994; 114: 328-30.
4. Steinberg D, Parthasarathy S, Carew TE, Witztum JL. Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med 1989; 320: 915-24.
5. Evensen SA, Galdal KS, Nilsen E. LDL-induced cytotoxicity and its inhibition by anti-oxidant treatment in cultured human endothelial cells and fibroblasts. Atherosclerosis 1983; 49: 23-30.
6. Morel DW, DiCorleto PE, Chisolm GM. Endothelial and smooth muscle cells alter low density lipoprotein in vitro by free radical oxidation. Arteriosclerosis 1984; 4: 357-64.
7. Holvoet P, Collen D. Oxidized lipoproteins in atherosclerosis and thrombosis. FASEB J 1994; 8: 1279-84.
8. Daugherty A, Roselaar SE. Lipoprotein oxidation as a mediator of atherogenesis: insights from pharmacological studies. Cardiovasc Res 1995; 29: 297-311.
9. Ardlie NG, Selley ML, Simons LA. Platelet activation by oxidatively modified low density lipoproteins. Atherosclerosis 1989; 76: 117-24.
10. Regnström J, Nilsson J, Törnvall P, Landou C, Hamsten A. Susceptibility to low-density lipoprotein oxidation and coronary atherosclerosis in man. Lancet 1992; 339: 1183-6.
11. Brown KM, Morrice PC, Duthie GG. Vitamin E supplementation suppresses indexes of lipid peroxidation and platelet counts in blood of smokers and nonsmokers but plasma lipoprotein concentrations remain unchanged. Am J Clin Nutr 1994; 60: 383-7.
12. Alexander RW. Theodore Cooper Memorial Lecture. Hypertension and the pathogenesis of atherosclerosis. Oxidative stress and the mediation of arterial inflammatory response: a new perspective. Hypertension 1995; 25: 155-61.
13. Raal FJ, Areias AJ, Waisberg R, von Arb M. Susceptibility of low density lipoprotein to oxidation in familial hypercholesterolaemia. Atherosclerosis 1995; 115: 9-15.
14. Janero DR. Therapeutic potential of vitamin E against myocardial ischemic-reperfusion injury. Free Radic Biol Med 1991; 10: 315-24
15. Halliwell B. Reactive oxygen species in living systems: source, biochemistry, and role in human disease. Am J Med 1991; 91 (suppl 3C): 14-22.
16. McDowell IFW, Brennan GM, McEneny J, Young IS, Nicholls DP, McVeigh GE et al. The effect of probucol and vitamin E treatment on the oxidation of low-density lipoprotein and forearm vascular responses in humans. Eur J Clin Invest 1994; 24: 759-65.
17. Szczeklik A, Gryglewski RJ, Domagala B, Dworski R, Basista M. Dietary supplementation with vitamin E in hyperlipoproteinemias: effects on plasma lipid peroxides, antioxidant activity, prostacyclin generation and platelet aggregability. Thromb Haemost 1985; 54: 425-30.
18. Reaven PD, Khouw A, Beltz WF, Parthasarathy S, Witztum JL. Effect of dietary antioxidant combinations in humans. Protection of LDL by vitamin E but not by beta-carotene. Arterioscler Thromb 1993; 13: 590-600.
19. Boberg KM. Betydningen av oksiderte lipoproteiner for ateroskleroseutvikling. Antioksidanter som behandlingsalternativ ved aterosklerose. Tidsskr Nor Lægeforen 1991; 111: 1861-5.
20. Tonstad S. Antioksidanter og hjerte- og karsykdom - epidemiologiske aspekter. Bør tilskudd anbefales for høyrisikopasienter? Tidsskr Nor Lægeforen 1995; 115: 227-9.
21. Verlangieri AJ, Bush MJ. Effects of d-alpha-tocopherol supplementation on experimentally induced primate atherosclerosis. J Am Coll Nutr 1992; 11: 131-8.
22. Morel DW, de la Llera-Moya M, Friday KE. Treatment of cholesterol-fed rabbits with dietary vitamins E and C inhibits lipoprotein oxidation but not development of atherosclerosis. J Nutr 1994; 124: 2123-30.
23. Kleinveld HA, Hak-Lemmers HL, Hectors MP, de Fouw NJ, Demacker PN, Stalenhoef AF. Vitamin E and fatty acid intervention does not attenuate the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbits. Arterioscler Thromb Biol 1995; 15: 290-7.
24. Hodis HN, Mack WJ, LaBree L, Casnin-Hemphill L, Sevanian A, Johnson R et al. Serial coronary angiographic evidence that antioxidant vitamin intake reduces progression of coronary artery atherosclerosis. JAMA 1995; 273: 1849-54.
25. Steiner M. Vitamin E: more than an antroxidant. Clin Cardiol 1993; 16 (suppl 1): 116-8
26. de Lorgeril M, Boissonnat P, Salen P, Monjaud I, Monnez C, Guidollet J et al. The beneficial effect of dietary antioxidant supplementation on platelet aggregation and cyclosporine treatment in heart transplant recipients. Transplantation 1994; 58: 193-5.
27. Boscoboinik D, Szewczck A, Hensey C, Azzi A Inhibition of cell proliferation by alpha-tocopherol. J Biol Chem 1991; 266: 6188-94.
28. Axford-Gately RA, Wilson GJ. Myocardial infarction size reduction by single high dose or repeated low dose vitamin E supplementation in rabbits. Can J Cardiol 1993; 9: 94-8.
29. Sebbag L, Forrat R, Canet E, Renaud S, Delaye J, de Lorgeril M. Effects of dietary supplementation with alpha-tocopherol on myocardial infarct size and ventricular arrhythmias in a dog model of ischemia-reperfusion. J Am Coll Cardiol 1994; 24: 1580-5.
30. Klein HH, Pich S, Nebendahl K, Niedmann P, Schuff-Werner P. Acute treatment with vitamin E does not protect the regionally ischemic, reperfused porcine heart. Basic Res Cardiol 1991; 86 32-9.
31. Coghlan JG, Flitter WD, Clutton SM, Ilsley CD, Rees A, Slater TF. Lipid peroxidation and changes in vitamin E levels during coronary artery bypass grafting. J Thorac Cardiovasc Surg 1993; 106: 268-74.
32. Barsacchi R, Pelosi G, Maffei S, Baroni M, Salvatore L, Ursini F et al. Myocardial vitamin E is consumed during cardiopulmonary bypass: indirect evidence of free radical generation in human ischemic heart. Int J Cardiol 1992, 37: 339-42.
33. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group. N Engl J Med 1994; 330: 1029-35.
34. Greenberg ER, Baron JA, Tosteson TD, Freeman DH, Beck GJ, Bond JH et al. A clinical trial of antioxidant vitamins to prevent colorectal adenoma. N Engl J Med 1994; 331: 141-7.
35. Kardinaal AFM, Vantveer P, Brants HAM, Vandenberg H, Vanschoonhoven J, Hermus RJJ. Relations between antioxidant vitamins in adipose tissue, plasma, and diet. Am J Epidemiol 1995; 141: 440-50.
36. Salonen JT, Salonen R, Seppanen K, Kantola M, Parviainen M, Alfthan G et al. Relationship of serum selenium and antioxidants to plasma lipoproteins, platelet aggregability and prevalent ischaemic heart disease in Eastern Finnish men Atherosclerosis 1988; 70: 155-60.
37. Kok FJ, de Bruijn AM, Vermeeren R, Hofman A, van Laar A, de Bruin M et al. Serum selenium, vitamin antioxidants, and cardiovascular mortality: a 9-year follow-up study in the Netherlands. Am J Clin Nutr 1987, 45: 462-8.
38. Gey KF, Brubacher GB, Stahelin HB. Plasma levels of antioxidant vitamins in relation to ischemic heart disease and cancer. Am J Clin Nutr 1987; 45: 1368-77.
39. Kardinaal AFM, Kok FJ, Ringstad J, Gomez-Aracena J, Mazaev VP, Kohlmeier L et al. Antioxidants in adipose tissue and risk of myocardial infarction: the EURAMIC study. Lancet 1993; 342: 1379-84.
40. Ocké MC, Schrijver J, Obermann-De Boer GL, Bloemberg BPM, Haenen GRMM, Kromhout D. Stability of blood (pro)vitamins during four years of storage at -20 degrees C: consequences for epidemiologic research. J Clin Epidemiol 1995; 48: 1077-85.
41. Luoma PV, Nayha S, Sikkila K, Hassi J. High serum alpha-tocopherol, albumin, selenium and cholesterol, and low mortality from coronary heart disease in northern Finland. J Intern Med 1995, 237: 49-54.
42. Riemersma RA, Wood DA, Macintyre CC, Elton RA, Gey KF, Oliver MF. Risk of angina pectoris and plasma concentrations of vitamins A, C, and E and carotene. Lancet 1991; 337: 1-5.
43. Street DA, Comstock GW, Salkeld RM, Schuep W, Klag MJ. Serum antioxidants and myocardial infarction. Are low levels of carotenoids and alpha-tocopherol risk factors for myocardial infarction? Circulation 1994; 90: 1154-61.
44. Todd S, Woodward M, Bolton-Smith C. An investigation of the relationship between antioxidant intake and coronary heart disease in men and women using logistic regression analysis. J Clin Epidemiol 1995; 48: 307-16.
45. Rimm EB, Stampfer MJ, Ascherio A, Giovannucci E, Colditz GA, Willett WC. Vitamin E consumption and the risk of coronary heart disease in men. N Engl J Med 1993; 328: 1450-6.
46. Stampfer MJ, Hennekens CH, Manson JE, Colditz GA, Rosner B, Willett WC. Vitamin E consumption and the risk of coronary disease in women. N Engl J Med 1993; 328: 1444-9.
47. Knekt P, Reunanen A, Jarvinen R, Seppanen R, Heliovaara M, Aromaa A. Antioxidant vitamin intake and coronary mortality in a longitudinal population study. Am J Epidemiol 1994; 139: 1180-9
48. Paolisso G, Gambardella A, Giugliano D, Galzerano D, Amato L, Volpe C et al. Chronic intake of pharmacological doses of vitamin E might be useful in the Therapy of elderly patients with coronary heart disease. Am J Clin Nutr 1995; 61: 848-52.
49. Paolisso G, D'Amore A, Galzerano D, Balbi V, Giugliano D, Varricchio M et al. Daily vitamin E supplements improve metabolic control but not insulin secretion in elderly type II diabetic patients. Diabetes Care 1993; 16: 1433-7.
50. Paolisso G, D'Amore A, Giugliano D, Ceriello A, Varricchio M, D'Onofrio F. Pharmacologic doses of vitamin E improve insulin action in healthy subjects and non-insulin-dependent diabetic patients. Am J Clin Nutr 1993; 57: 650-6.
51. Anderson TW. Vitamin E in angina pectoris. Can Med Assoc J 1974; 110: 401-6.
52. Gillilan RE, Mondell B, Warbasse JR. Quantitative evaluation of vitamin E in the treatment of angina pectoris. Am Heart J 1977; 93; 444-9.
53. Rinzler SH, Bakst H, Benjamin ZH, Bobb AL, Travell J. Failure of alpha tocopherol to influence chest pain in patients with heart disease. Circulation 1950; 1: 288-93.
54. DeMaio SJ, King SB, Lembo NJ, Roubin GS, Hearn JA, Bhagavan HN et al. Vitamin E supplementation, plasma lipids and incidence of restenosis after percutaneous transluminal coronary angioplasty (PTCA). J Am Coll Nutr 1992; 11: 68-73.
55. Princen HMG, Vanduyvenvoorde W, Buytenhek R, Vanderlaarse A, Vanpoppel G, Leuven JAG et al. Supplementation with low doses of vitamin E protects LDL from lipid peroxidation in men and women. Arterioscler Thromb Vasc Biol 1995; 15: 325-33.
56. Jialal I, Fuller CJ, Huet BA. The effect of α-tocopherol supplementation on LDL oxidation. Arterioscler Thromb Vasc Biol 1995; 15: 190-8.
57. Keaney JF jr., Gaziano JM, Xu A, Frei B, Curran-Celentano J, Shwaery GT et al. Low-dose alpha-tocopherol improves and high-dose alpha-tocopherol worsens endothelial vasodilator function in cholesterol-fed rabbits. J Clin Invest 1994; 93: 844-51.
58. Jialal I, Grundy SM. Effect of combined supplementation with alpha-tocopherol, ascorbate, and beta carotene on low-density lipoprotein oxidation. Circulation 1993; 88: 2780-6.
59. Bendich A, Machlin LJ. Safety of oral intake of vitamin E. Am J Clin Nutr 1988; 48: 612-9.
60. Buring JE, Hennekens CH. The Women's Health Study: summary of the study design. J Myocard Ischemia 1992; 4: 27-9.
61. Higgins G. HOPE is here for patients at high risk of cardiovascular mortality. Inpharma 1994; 955: 3-4.